What is PatientsLikeMe?
Founded in 2004 and headquartered in Boston, PatientsLikeMe operates as a sophisticated patient network and real-time research platform. By facilitating a digital environment where individuals living with chronic conditions can connect, track their health outcomes, and share experiential data, the company has established itself as a vital source of patient-centric insights. This data-driven approach allows for the aggregation of longitudinal health information, which is increasingly valuable for pharmaceutical research, clinical trial optimization, and the advancement of personalized medicine. The company's market position is defined by its unique ability to transform anecdotal patient experiences into actionable, structured medical intelligence.
How much funding has PatientsLikeMe raised?
PatientsLikeMe has raised a total of $156M across 7 funding rounds:
Series A
$5M
Private Equity
$8M
Private Equity
$12M
Private Equity
$3M
Private Equity
$2M
Private Equity
$100M
Other Financing Round
$26M
Series A (2007): $5M with participation from Omidyar Network, CommerceNet, and Invus
Private Equity (2010): $8M, investors not publicly disclosed
Private Equity (2012): $12M, investors not publicly disclosed
Private Equity (2012): $3M, investors not publicly disclosed
Private Equity (2013): $2M, investors not publicly disclosed
Private Equity (2017): $100M with participation from iCarbonX and Invus
Other Financing Round (2021): $26M led by Optum Ventures, Hambrecht Ducera Growth Ventures, Alta Partners LLC, and PBM Capital
Key Investors in PatientsLikeMe
iCarbonX
A digital health pioneer focused on building a global platform for digitizing and analyzing life through multi-omics, artificial intelligence, and experiential data.
Omidyar Network
A philanthropic investment firm that supports visionaries and innovators to promote shared power and prosperity through the digital revolution.
Invus
An established investment firm founded in 1985 that provides strategic financial advice and capital to support long-term growth initiatives.
What's next for PatientsLikeMe?
With the infusion of $26M, PatientsLikeMe is well-positioned to accelerate its enterprise-level growth strategy. The focus is expected to shift toward enhancing the interoperability of its data platform with broader healthcare ecosystems, including integration with electronic health records and advanced analytics suites. By leveraging its deep repository of multi-omics and experiential data, the company aims to refine its predictive modeling capabilities, ultimately driving more efficient drug development cycles and improving patient outcomes. As the healthcare industry continues to prioritize real-world evidence, PatientsLikeMe remains a critical partner for stakeholders seeking to navigate the complexities of modern condition management and therapeutic innovation.
See full PatientsLikeMe company page
